Arformoterol Tartrate Solution
Product Images NDC 72603-208

12 FDA label images from Northstar Rxllc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 72603-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 01)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 01)
Chemical structure of arformoterol tartrate, depicting the molecular arrangement of its active ingredient components.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 02)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 02)
A line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 0 (Day 1)' showing mean change from baseline FEV1 (L) on the vertical axis and hours postdose on the horizontal axis. Two lines represent data for placebo and 15 mcg arformoterol tartrate inhalation solution BID. The arformoterol line shows a higher increase in FEV1 compared to placebo over 12 hours postdose.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 03)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 03)
A line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 12,' showing mean change from baseline FEV1 in liters on the vertical axis and hours postdose on the horizontal axis, up to 12 hours. Two lines compare placebo and arformoterol tartrate 15 mcg inhalation solution BID effects, with arformoterol showing a positive increase in FEV1 that peaks early and gradually declines, while placebo shows minimal change.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 04)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 04)
An instructional line drawing illustrating how to open a vial or reservoir for a respiratory inhalation solution. The image shows hands gripping the vial and lifting or twisting the cap upward to remove it. There are arrows indicating the direction of the motion to open the vial.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 05)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 05)
An instructional diagram showing a hand holding an inhaler device with a labeled reservoir. The illustration likely demonstrates how to prepare or use the inhalation solution product arformoterol tartrate by interacting with the reservoir component.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 06)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 06)
Illustration showing two figures: Figure 3 depicts a mouthpiece attached to a respiratory solution device; Figure 4 shows a face mask attached to the same device. The images likely demonstrate inhalation options for arformoterol tartrate respiratory solution.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 07)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 07)
An illustration showing a respiratory inhalation setup with a labeled compressor unit and tubing connection. The image depicts the compressor device with a control knob and a display, connected to tubing for inhalation use.*
FDA Label Image

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 08)

Image (C3d670fd 671b 4c32 A9ca 448dc6a49c66 08)
An instructional illustration showing a person using a respiratory inhalation device, demonstrating the position of the mouth around the inhaler mouthpiece for correct administration.*
FDA Label Image

Pouch 1 Unit (C3d670fd 671b 4c32 A9ca 448dc6a49c66 09)

Pouch 1 Unit (C3d670fd 671b 4c32 A9ca 448dc6a49c66 09)
Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, a respiratory inhalation solution supplied as one 2 mL sterile unit-dose vial. The label features the NorthStar Rx LLC logo and details such as NDC 72603-208-01, storage instructions, and administration precautions. It is marked Rx only.*
FDA Label Image

5s Foil (C3d670fd 671b 4c32 A9ca 448dc6a49c66 10)

5s Foil (C3d670fd 671b 4c32 A9ca 448dc6a49c66 10)
Label for arformoterol tartrate inhalation solution, 15 mcg per 2 mL, Rx only. The label specifies it comes in four 2 mL sterile unit-dose vials. It includes storage instructions to keep unused vials in the foil pouch and warnings to keep out of reach of children. Manufactured and labeled by NorthStar Rx LLC.*
FDA Label Image

30 Carton (C3d670fd 671b 4c32 A9ca 448dc6a49c66 11)

30 Carton (C3d670fd 671b 4c32 A9ca 448dc6a49c66 11)
Packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by NorthStar Rx LLC. The product is a respiratory inhalation solution supplied in sterile unit-dose vials with a package count of 30 x 2 mL. The label highlights storage instructions to keep refrigerated or store at room temperature for up to 6 weeks and includes NDC 72603-208-30.*
FDA Label Image

60 (C3d670fd 671b 4c32 A9ca 448dc6a49c66 12)

60 (C3d670fd 671b 4c32 A9ca 448dc6a49c66 12)
Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by NorthStar Rx LLC. The product consists of 60 sterile unit dose vials, each containing 2 mL of solution. The label includes storage instructions to keep refrigerated or at room temperature up to 6 weeks, along with manufacturer details and usage as an oral inhalation solution for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.